Xu, Lin http://orcid.org/0000-0001-5815-4457
Pierce, Joshua L. http://orcid.org/0000-0002-2773-6793
Sanchez, Angelica
Chen, Kenneth S. http://orcid.org/0000-0003-2304-4631
Shukla, Abhay A.
Fustino, Nicholas J.
Stuart, Sarai H. http://orcid.org/0009-0006-3591-9107
Bagrodia, Aditya
Xiao, Xue
Guo, Lei
Krailo, Mark D.
Shaikh, Furqan
Billmire, Deborah F.
Pashankar, Farzana http://orcid.org/0000-0003-2883-0957
Bestrashniy, Jessica
Oosterhuis, J. Wolter http://orcid.org/0000-0002-6685-686X
Gillis, Ad J. M.
Xie, Yang
Teot, Lisa
Mora, Jaume http://orcid.org/0000-0002-9386-5980
Poynter, Jenny N. http://orcid.org/0000-0002-8460-3938
Rakheja, Dinesh http://orcid.org/0000-0001-6888-7902
Looijenga, Leendert H. J. http://orcid.org/0000-0002-8146-1911
Draper, Bruce W. http://orcid.org/0000-0002-4397-7749
Frazier, A. Lindsay http://orcid.org/0000-0003-4748-8552
Amatruda, James F. http://orcid.org/0000-0002-9901-2137
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA135731, T32 CA099936)
Cancer Prevention and Research Institute of Texas (RP110394)
St. Baldrick’s Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 19 April 2020
Accepted: 26 April 2023
First Online: 6 May 2023
Competing interests
: A.L.F.: Clinical Advisory Board, stock and compensation from Decibel Therapeutics. The remaining authors declare no competing interests.